Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome

Urology

Volumn 79, Issue 5, 2012, Pages 1187.e1-1187.e7

  Mester, Jessica L ^a,b   Zhou, Ming ^a,b   Prescott, Nichole ^a   Eng, Charis ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HAMARTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; PTEN HAMARTOMA TUMOR SYNDROME; SCHOOL CHILD;

EID: 84860484167     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.12.025     Document Type: Article

References (30)

1. D.J. Marsh, J.B. Kum, K.L. Lunetta PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome Hum Mol Genet 8 1999 1461 1472 (Pubitemid 29374079)
2. K.M. Zbuk, C. Eng Cancer phenomics: RET and PTEN as illustrative models Nat Rev Cancer 7 2007 35 45 (Pubitemid 46020845)
3. T.M. Starink, J.P. van der Veen, F. Arwert The Cowden syndrome: a clinical and genetic study in 21 patients Clin Genet 29 1986 222 233 (Pubitemid 16136974)
4. E.D. Lynch, E.A. Ostermeyer, M.K. Lee Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis Am J Hum Genet 61 1997 1254 1260 (Pubitemid 28046900)
5. L.M. Capitan Canadas, J.L. Salinas Sanchez, S.L. Martinez Castillo Multiple oral fibropapillomatosis as an initial manifestation of Cowden Syndrome Case report Med Oral Patol Oral Cir Bucal 11 2006 E319 E324
6. R. Pilarski, C. Eng Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome J Med Genet 41 2004 323 326 (Pubitemid 38608513)
7. W. Brenner, G. Färber, T. Herget Loss of tumor suppressor protein PTEN during renal carcinogenesis Int J Cancer 99 2002 53 57 (Pubitemid 34273197)
8. S.P. Guo, Y.Q. Zhai, W.L. Wang Expression and significance of a new tumor suppression gene PTEN in primary renal cell carcinoma Ai Zheng 21 2002 582 587
9. M. Hager, H. Haufe, R. Kemmerling PTEN expression in renal cell carcinoma and oncocytoma and prognosis Pathology 39 2007 482 485 (Pubitemid 47450589)
10. S. Hara, M. Oya, R. Mizuno Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor Ann Oncol 16 2005 928 933 (Pubitemid 40903919)
11. K. Kondo, M. Yao, K. Kobayashi PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines Int J Cancer 91 2001 219 224 (Pubitemid 32041743)
12. J. Shin Lee, H. Seok Kim, Y. Bok Kim Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth J Surg Oncol 84 2003 166 172
13. T. Klatte, A.J. Pantuck, J.W. Said Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma Clin Cancer Res Off J Am Assoc Cancer Res 15 2009 1162 1169
14. M.H. Tan, J. Mester, C. Peterson A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands Am J Hum Genet 88 2011 42 56
15. G. Kovacs, M. Akhtar, B.J. Beckwith The Heidelberg classification of renal cell tumours J Pathol 183 1997 131 133
16. B.C. Leibovich, C.M. Lohse, P.L. Crispen Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma J Urol 183 2010 1309 1315
17. H.T. Lynch, R.M. Fusaro, J. Lynch Hereditary cancer in adults Cancer Detect Prev 19 1995 219 233
18. H. Shen-Li, S. Koujak, M. Szablocs Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice Cancer Biol Ther 10 2010 1194 1200
19. K.L. Wang, D.M. Weinrach, C. Luan Renal papillary adenoma - a putative precursor of papillary renal cell carcinoma Hum Pathol 38 2007 239 246 (Pubitemid 46096548)
20. M.P. Myers, J.P. Stolarov, C. Eng P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proc Natl Acad Sci U S A 94 1997 9052 9057
21. J.H. Chung, C. Eng Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis Cancer Res 65 2005 8096 8100 (Pubitemid 41330571)
22. M.H. Tan, J. Ngeow, L. Rybicki Lifetime cancer risks in individuals with germline PTEN mutations Clin Cancer Res 2012 In press
23. P.L. Choyke, M.M. Walther, G.M. Glenn Imaging features of hereditary papillary renal cancers J Comput Assist Tomogr 21 1997 737 741 (Pubitemid 28049618)
24. M. Mvundura, S.D. Grosse, H. Hampel The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer Genet Med 12 2010 93 104
25. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996 J Clin Oncol 14 1996 1730 1736
26. R.A. Smith, V. Cokkinides, H.J. Eyre American Cancer Society guidelines for the early detection of cancer CA Cancer J Clin 2006 2006 11 25 (Pubitemid 43228384)
27. D. Saslow, C. Boetes, W. Burke American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2007 75 89 (Pubitemid 46535708)
28. Y. Ni, K.M. Zbuk, T. Sadler Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes Am J Hum Genet 83 2008 261 268
29. K.L. Bennett, J. Mester, C. Eng Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome JAMA 304 2010 2724 2731
30. C.J. Ricketts, J.R. Forman, E. Rattenberry Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD Hum Mutat 31 2010 41 51